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Abstract
So far, rt – PA remains the best treatment for ischemic stroke within 
the 3-6 hour window after the onset. However, the majority of isch-
emic stroke patients do not receive rt – PA treatment due to various 
reasons and they can only accept the treatment which prevents a 
second attack. The Chinese herbal decoction – Xuming Tang has been 
recorded as an effective treatment for stroke in the traditional Chinese 
medicine book. Recently it has been tested in over 1,500 patients who 
started taking this herbal decoction from 2.5 hours to days after the 
onset of stroke in randomised and quasi-randomised trials. It has been 
shown that approximately 1/3 of the stroke patients fully recovered 
and another 1/3 improved dramatically after the treatment period. 
Compared with the data from the control group which received either 
conventional therapy (this prevents a second attack) or conventional 
therapy in combination with other Chinese herbal decoctions, Xuming 
Tang is a better choice for ischemic stroke patients who are ineligible 
for rt – PA thrombolysis within 3-6 hour window or who miss this 
time window. 
Facts about Ischemic stroke 
and its treatment
Ischemic stroke is the most common type of stroke 
worldwide. Each year over 2 million patients are 
diagnosed with this disease and the cost of medi-
cal care for these patients has been dramatically 
increasing in China1. 
So far, rt – PA remains the most effective treatment 
for ischemic stroke within 3 hours onset2. There are 
clinical trials extending the time window for using 
rt – PA to 4.5hours 3-6 or 6 hours 7-9. Certain groups 
of ischemic stroke patients are likely to benefit from 
this. However, the fact is that less than 20% of pa-
tients can receive rt – PA due to the delay in visiting 
a hospital or being excluded from receiving rt – PA 
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thrombolysis 10-15. Therefore, the majority of isch-
emic stroke patients are treated with conventional 
medications for secondary prevention. Though a 
considerable proportion of ischemic stroke patients 
will recover with these medications and the sub-
sequent rehabilitation, most of these patients will 
be left with either disability or apparent symptoms. 
This poses a large burden for the patients, carers, 
and the health care system. 
Xuming Tang for ischemic 
stroke
Xuming Tang is a Chinese herbal decoction for stroke 
treatment recorded in “Xiaopin Fang” by a Chinese 
medicine doctor Yanzhi Chen living in the period 
of 420AC-589AC16. This herbal decoction has been 
refined by other Chinese medicine doctors after 
him. The main ingredients include ephedra, semen 
armeniacae amarum, rambles cinnamomi, rhizome 
chuanxiong, radix angelica sinensis, radix glycyrrhi-
zae, dry ginger, gypsum fibrosum, radix codonopsis. 
These are the same for all patients. Other herbs are 
also included based on the condition of the patients. 
For example, patients with too much “Yang” will re-
ceive radix scutellariae, radix trichosanthis, rhizoma 
anemarrhenae, and patients with too much “Cold” 
will receive aconitum carmichaeli debx, herba asari, 
pericarpium zanthoxyli. According to the Chinese 
medicine theory, this herbal decoction activates the 
circulation to resolve blood stasis, dispels interior 
and exterior “Wind”, tonifies “Qi” and blood, clears 
extra “Heat”, disperses “Qi”, removes “Dampness”, 
and induces diuresis to alleviate edema. As a result, 
the upward and downward transportation of nutri-
ents absorbed in the “Stomach” and “Spleen” is 
restored and resuscitation is achieved 17. From the 
point view of western medicine, this decoction pro-
tects the brain tissue by stopping the influx of ex-
tracellular calcium and minimizing the permeability 
of capillaries18,19, prevents further injury caused by 
NO, oxidized lipids20, and calcium; lowers the blood 
pressure in hypertensive patients and the level of lip-
ids including cholesterol and triglycerol20,21, inhibits 
the aggregation of platelets and the formation of 
thrombus, prolongs the time of coagulation, and 
improves the blood supply to the brain19. 
Recently, many Chinese medicine doctors began to 
test its efficacy for stroke, especially ischemic stroke, 
through randomized or quasi-randomised trials (see 
table 1). They recruited patients with ischemic stroke 
arriving at the hospital 2.5 hours to over 5 days 
after the onset. Both male and female patients at 
any age were included. These patients were divid-
ed into two groups. The treatment group received 
Xuming Tang decoction and the control group re-
ceived either placebo or conventional medications 
for secondary prevention, or conventional medica-
tions with other Chinese herbal recipes for ischemic 
stroke. The treatment period varied from 8 days to 
8 months with a majority between 2 weeks and 6 
weeks. The result from meta-analysis of these trials 
showed that approximately one third of the patients 
in the treatment group fully recovered without any 
symptoms or signs of neurological deficits, whereas 
only 23% of the patients in the control groups fully 
recovered. Apart form this, slightly over one third 
of the patients in the treatment group had appar-
ent improvement demonstrated by a reduction of 
45-90% of neurological deficit scale and a 2 grades 
increase in muscle strength. In comparison, only 
about a quarter of patients in the control group 
had the same improvement. 
These results show that Xuming Tang decoction 
is an effective therapy for ischemic stroke patients 
who miss the 3-6 hour window for rt – PA throm-
bolysis. It not only reduces the chance of getting 
disabled but also cures some of the patients as rt 
– PA does in timely treated patients. Therefore, it 
reduces the burden of the patients, carers, and the 
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Table 1. Data from published articles
Xuming Tang control
Authors year group 1 group 2 group 3 group 4 total group 1 group 2 group 3 group 4 total
Gu 1989 118 56 17 9 200*
Huang 1989 46 41 1 88*
Hu 1995 26 52 19 1 98*
Yu 1996 20 6 4 0 30 12 4 6 6 28
Chen 1997 10 11 9 1 31 3 7 7 3 20
Yu 1998 22 24 12 2 60 6 10 9 5 30
Zhan 1999 8 16 6 2 32 5 9 11 3 28
Zhang 1999 42 36 19 15 112*
Lv 2006 12 15 7 6 40 4 10 6 18 38
Hu 2010 15 16 9 5 45 8 8 14 11 41
Tian 2010 14 20 1 35 11 17 3 31
Zhang 2011 5 14 8 3 30 4 9 9 8 30
Zhou 2011 9 23 6 2 40 5 22 11 2 40
Liu 2012 21 10 5 2 38 16 9 7 5 37
LiG 2012 16 29 5 50 11 26 13 50
LiJ 2012 65 28 8 101 42 34 21 97
Li 2013 15 11 2 28*
Gong 2013 7 13 8 2 30 3 8 4 5 30
Total 395 379 247 67 1088 108 118 171 103 500
n% 35.8(33.6) 36.0(34.3) 22.3(25.4) 5.9(6.4) 100 23.1 24.5 32.2 20.3 100
group 1: cured or with no neurological deficits
group 2: dramatic improvement by 2 grades increase in muscle strength
group 3: improvement by 1 grade increase in muscle strength
group 4: no changes or get worse
*indicates no control groups
N(n): N indicates percentage by including the trials without control groups, (n) indicates percentage by excluding the trials 
without control groups.
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health system. It brings hope to those patients with 
ischemic stroke and their treatment with rt -PA is 
delayed or excluded due to various reasons.
Questions and the future of 
Xuming Tang
Undoubtedly, the above results will be questioned 
concerning the method used in these clinical trials. 
Firstly, the time range of arriving at the hospital af-
ter the onset of ischemic stroke has a large variation. 
This time difference will influence the randomization 
and the subsequent analysis of the result. Secondly, 
each patient is receiving different combinations of 
herbs. This poses a question about the efficacy of 
the herbs which differ between patients. Thirdly, 
the treatment period varies dramatically between 
patients, which affects the evaluation of neurologi-
cal deficits, muscle strength, and disability. 
Among these trials, some of the investigators ana-
lyzed the efficacy of Xuming Tang on different types 
of stroke based on the diagnosis by Chinese medi-
cine doctors. They found that Xuming Tang is more 
effective for patients with “Wind” and “Phlegm” 
stasis, or “Dampness-Phlegm syndrome” than those 
with any other forms of stroke22. This indicates that 
multiple mechanisms are responsible for stroke de-
velopment. Therefore, treatment for each stroke 
patient should be tailored. 
Some investigators studied the effect of Xuming 
Tang on intracerebral hemorrhage and found that 
patients with intracerebral hemorrhage also benefit 
from this decoction compared with the convention-
al therapy23. This highlights the commonality shared 
by the ischemic and hemorrhagic stroke in disease 
etiology, development, and treatment. 
These challenges require further better designed, 
large scaled trials to verify the proficiency of Xuming 
Tang on ischemic stroke patients who are treated 6 
hours after the onset. If this is confirmed, it might 
be necessary to compare the efficacy of Xuming 
Tang with that of rt – PA in ischemic stroke pa-
tients who are treated within 3 or 6 hours after the 
onset. After all, this is a hope for ischemic stroke 
patients who are either ineligible for rt – PA throm-
bolysis within the 3-6 hour window or who miss 
the time window for rt – PA thrombolysis. Further-
more, more research is encouraged to investigate 
the cause, mechanism, and therapeutics of both the 
ischemic and hemorrhagic stroke.  
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